Na-Ri Oh, MD is a biotech investor with Black Canyon Ventures and a Cohort V VC fellow with Material Change Institute. She has extensive experience in the biopharmaceutical industry where she worked as a global marketing and strategy executive with a focus on life-threatening infectious and rare diseases. Before joining the pharmaceutical industry, she practiced medicine as an Infectious Disease physician.

Na-Ri was born and raised in Germany where she earned a BS in Biochemistry and Molecular Biology from University of Hamburg and an MD from Ruprecht-Karl-University of Heidelberg, Germany’s oldest university. She was also a Visiting Undergraduate at Harvard University.